Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Possible side effects include mild nausea, headaches, or skin rashes
The temporary program, running from July 2026 through December 2027, does not change the current statutory prohibition on Medicare coverage of drugs used for weight loss but instead is being established using the federal governments Section 402 demonstration authority
Not all GLP-1s are approved for obesity treatment, and this analysis includes all FDA-approved GLP-1s, including those approved for obesity (Saxenda, Weogvy, Zepbound) as well as those approved for type 2 diabetes (see Table 1)
Choose Your GLP-1 Plan Tirzepatide Most Powerful Option Strong appetite control for faster and more effective weight loss
US$ 21.89
US$ 28.50
US$ 22.88
